1,203 Shares in HCA Healthcare, Inc. (NYSE:HCA) Acquired by Neo Ivy Capital Management

Neo Ivy Capital Management purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,203 shares of the company’s stock, valued at approximately $361,000.

A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Norges Bank bought a new position in HCA Healthcare during the 4th quarter valued at $840,286,000. Royal London Asset Management Ltd. grew its holdings in HCA Healthcare by 62.0% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock worth $450,461,000 after acquiring an additional 574,239 shares during the period. Barclays PLC lifted its holdings in HCA Healthcare by 85.7% in the 4th quarter. Barclays PLC now owns 1,061,891 shares of the company’s stock valued at $318,727,000 after acquiring an additional 489,916 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock worth $262,264,000 after purchasing an additional 476,756 shares in the last quarter. Finally, Two Sigma Investments LP grew its position in HCA Healthcare by 12,016.0% in the fourth quarter. Two Sigma Investments LP now owns 467,437 shares of the company’s stock worth $140,301,000 after buying an additional 463,579 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent research reports. Baird R W cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Monday, April 28th. Robert W. Baird reissued a “neutral” rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Finally, Bank of America decreased their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $381.13.

HCA Healthcare Trading Up 0.1%

NYSE:HCA opened at $376.86 on Friday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company has a market capitalization of $90.66 billion, a P/E ratio of 17.15, a P/E/G ratio of 1.10 and a beta of 1.46. The stock’s 50 day moving average price is $346.75 and its 200 day moving average price is $329.44. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same quarter in the previous year, the business earned $5.36 EPS. HCA Healthcare’s quarterly revenue was up 5.7% compared to the same quarter last year. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare’s dividend payout ratio is 12.81%.

Insider Buying and Selling

In other news, COO Jon M. Foster sold 15,698 shares of the firm’s stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.